Take Care opens new Scottsdale clinic
SCOTTSDALE, Ariz. Walgreens’ clinic division, Take Care Health Systems, announced the addition of its newest clinic here Thursday.
The new clinic, located at the Walgreens store at 7011 East Shea Blvd., in Scottsdale, Ariz., makes No. 19 in the area for Take Care. In all, Take Care currently operates 346 retail-based clinics in 35 different markets.
Take Care Health Systems expands treatment for skin conditions, minor injuries
CONSHOHOCKEN, Pa. Take Care Health Systems is offering a new set of procedures for skin conditions and minor injury treatments.
As part of this expansion of services, Take Care Clinics now offer the following procedures:
- Wart removal with cryotherapy;
- Skin tag removal;
- Closure of minor cuts with dermabond;
- Treatment of skin irritations (Contact Dermatitis); and
- Expanded scope of skin evaluation and treatment for skin infections, injuries and rashes.
The addition of these new services is a result of feedback from patients, Take Care health providers and recent research, which identified a desire for the treatment of these types of skin conditions in the convenient care setting. According to the Department of Health and Human Services, over 48 million skin examinations are conducted each year, which result in 3.2 million viral wart procedures and 3.3 million skin tag removals.
“Patients are very satisfied with the service and offerings at Take Care Clinics, and we’ve found that they are looking for additional high-quality, convenient and affordable treatment options in our care setting,” said Peter Miller, Take Care Health Systems’ president and CEO. “We will continue to evaluate and implement new services which meet the needs of patients and can be offered with clinical excellence at Take Care Clinics.”
Take Care Health Systems currently manages 345 Take Care Clinics at Walgreens drug stores in 35 markets across 19 states.
Importation amendment fails to advance, drawing NACDS praise for Senate panel
ALEXANDRIA, Va. A move in the U.S. Senate to block legislation that would have allowed the reimportation of prescription drugs from Canada and other nations drew quick praise Wednesday from the National Association of Chain Drug Stores.
The drug reimportation amendment, offered in the Senate Health, Education, Labor and Pensions Committee as part of broad health care reform proposals, failed to advance by a vote of 12 to 10. In response, NACDS president and CEO Steven Anderson sent a letter praising the dozen committee members who voted against the proposal.
“This was an important legislative victory for patient health and prescription drug safety,” NACDS stated.
Senators opposing the reimportation amendment on the HELP Committee included Senators Lamar Alexander (R-Tenn.), Jeff Bingaman (D-N.M.), Richard Burr (R-N.C.), Mike Enzi (R-Wy.), Judd Gregg (R-N.H.), Kay Hagan (D-N.C.), Orrin Hatch (R-Utah), Johnny Isakson (R-Ga.), Barbara Mikulski (D-Md.), Lisa Murkowski (R-Ark.), Patty Murray (D-Wash.), and Pat Roberts (R-Kan.).
In his letter to those committee members, Anderson reaffirmed that “NACDS is committed to reducing the cost of and increasing access to prescription drugs.” However, he pointed out, “We do not believe that patient safety can be ensured in any system that allows for the importation of prescription medications.
“In addition to questions concerning the safety and effectiveness of these drugs, those who obtain prescription medications through importation schemes do not have a qualified, licensed pharmacist available to consult with regarding safe and effective use of prescription medications,” Anderson told lawmakers.
The NACDS executive also argued that there are safer and more effective alternatives to reducing prescription drug costs for Americans. “Every day,” he wrote, “retail pharmacists assist customers with obtaining the most cost effective, therapeutically appropriate drug therapies, including affordable and effective generic drugs.”
In particular, said Anderson, “The generic dispensing rate at retail pharmacies is 64.5% – higher than any other pharmacy practice setting. We urge Congress to adopt policies that will bring more generic drugs to market and to create incentives for doctors to prescribe and pharmacies to dispense generic medications.
“One of the most critical ways to do this is by reforming the Medicaid ‘average manufacturer price’ system, which, as currently written, will reimburse pharmacies one-third less than what it costs them to purchase generic medications,” Anderson added. “Congress should create incentives for generic drugs, not disincentives.”